ptp1b inhibitors with the following structure . experiments indicate that these inhibitors can effectively inhibit the activity of protein tyrosine phosphatase 1b . they can be used as insulin sensitisers . they can be used to prevent , delay or treat diseases which are related to insulin antagonism mediated by ptp1b , especially diabetes type ii and obesity . the invention also provides methods for preparing these inhibitors .